GlaxoSmithKline Pakistan Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9,910	8,592	6,513	3,611	4,755	7,085
Short-Term Investments	-	-	-	-	-	1,633
Cash & Short-Term Investments	9,910	8,592	6,513	3,611	4,755	8,719
Cash Growth	60.16%	31.91%	80.39%	-24.06%	-45.47%	43.98%
Accounts Receivable	3,211	2,813	555.14	1,028	1,585	1,316
Other Receivables	9,763	8,991	10,337	7,506	5,582	1,669
Receivables	15,026	11,858	10,947	8,587	7,217	3,043
Inventory	13,212	13,068	11,447	11,794	9,726	6,696
Prepaid Expenses	-	185.98	181.1	190.75	123	7.21
Other Current Assets	353.13	1,452	1,610	1,158	1,682	503.93
Total Current Assets	38,501	35,156	30,698	25,341	23,503	18,969
Property, Plant & Equipment	14,386	14,433	13,262	11,701	10,997	10,408
Goodwill	955.74	955.74	955.74	955.74	955.74	955.74
Other Intangible Assets	-	-	-	-	-	36
Other Long-Term Assets	50.15	50.15	50.15	50.15	27.52	22.01
Total Assets	53,990	50,684	45,055	38,131	35,542	30,455
Accounts Payable	15,445	1,308	1,089	1,616	560.52	652.17
Accrued Expenses	-	8,237	7,147	5,404	4,098	3,776
Short-Term Debt	-	246.51	198.63	572.93	284.14	235.75
Current Portion of Leases	20.88	32.97	27.89	35.94	16.5	20.89
Current Income Taxes Payable	-	989.29	1,443	68.69	936.81	1,116
Current Unearned Revenue	-	1,833	1,971	2,432	2,368	1,051
Other Current Liabilities	392.93	2,487	3,057	4,436	4,645	1,479
Total Current Liabilities	15,858	15,134	14,933	14,565	12,909	8,330
Long-Term Leases	334.19	335.14	145.76	116.04	45.42	32.71
Pension & Post-Retirement Benefits	659.05	612.44	636.36	593.71	577.8	298.89
Long-Term Deferred Tax Liabilities	853.35	927.43	1,064	1,181	957	806.63
Total Liabilities	17,705	17,009	16,779	16,455	14,489	9,469
Common Stock	3,185	3,185	3,185	3,185	3,185	3,185
Retained Earnings	31,974	29,363	23,965	17,364	16,742	16,675
Comprehensive Income & Other	1,127	1,127	1,127	1,127	1,127	1,127
Shareholders' Equity	36,285	33,675	28,277	21,676	21,053	20,987
Total Liabilities & Equity	53,990	50,684	45,055	38,131	35,542	30,455
Total Debt	355.07	614.63	372.28	724.9	346.07	289.36
Net Cash (Debt)	9,555	7,978	6,141	2,886	4,408	8,429
Net Cash Growth	64.08%	29.90%	112.80%	-34.54%	-47.70%	48.37%
Net Cash Per Share	30.00	25.05	19.28	9.06	13.84	26.47
Filing Date Shares Outstanding	318.38	318.47	318.47	318.47	318.47	318.47
Total Common Shares Outstanding	318.38	318.47	318.47	318.47	318.47	318.47
Working Capital	22,643	20,022	15,766	10,776	10,595	10,639
Book Value Per Share	113.97	105.74	88.79	68.06	66.11	65.90
Tangible Book Value	35,330	32,719	27,321	20,720	20,097	19,995
Tangible Book Value Per Share	110.97	102.74	85.79	65.06	63.11	62.78
Land	-	316.41	316.41	316.41	316.41	316.41
Buildings	-	3,404	3,102	3,080	3,001	2,928
Machinery	-	15,839	14,393	13,856	12,773	12,119
Construction In Progress	-	3,333	3,087	1,295	1,236	1,178

Source: S&P Global Market Intelligence. Standard template. Financial Sources.